RxDoctor Payments Data

Luis Castro, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Redwood City, CANPI 1679587893

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (27.9%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Abbott accounts for 64.7% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2020 at $9,214 and has fallen 64.5% since, to $3,276 in 2025.

$30,508in general payments, 2019–2025

Across 136 payments — averaging $224.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$20K
  • Atricure, Inc.$5K
  • Medtronic$4K
  • Edwards Lifesciences$1K
  • Baxter Healthcare$195
  • Clearflow Inc.$138
  • plus $161 from 6 others
$24,834in research payments, 2019–2025

Across 11 payments — averaging $2257.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Atricure, Inc.$25K

What the payments were for

  • Consulting fees$6,50021%
  • Speaking & faculty fees$8,52528%
  • Grants$1,1234%
  • Travel & lodging$6,27321%
  • Food & beverage$7,90026%
  • Education$420%
  • Other$1450%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$30,508 in reported general payments places this provider in the 80th percentile of 546 thoracic surgery (cardiothoracic vascular surgery) providers in California.

See all thoracic surgery (cardiothoracic vascular surgery) providers in California →

Medicare billing

Part B allowed, 2024
$365,908
Medicare patients
192
Services billed
509

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Torsemide12$102
Tramadol Hcl13$32

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Redwood City

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →